Hormonal and cytokine effects of uric acid

Current Opinion in Nephrology and Hypertension

Volumn 15, Issue 1, 2006, Pages 30-33

  Sánchez Lozada, Laura G ^a   Nakagawa, Takahiko ^b   Kang, Duk Hee ^c   Feig, Dan I ^d   Franco, Martha ^a   Johnson, Richard J ^b   Herrera Acosta, Jaime ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSITY OF FLORIDA   (United States)

^c Ewha Womans University School of Medicine   (South Korea)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Arteriosclerosis; Hypertension; Renal disease; Uric acid

Indexed keywords

ANTIOXIDANT; CYCLOOXYGENASE 2; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; ORGANIC ANION TRANSPORTER; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR C; TRANSCRIPTION FACTOR; URIC ACID;

ARTERIAL PRESSURE; ARTERIOSCLEROSIS; CELL PROLIFERATION; CYTOKINE RELEASE; ENZYME DEGRADATION; GLOMERULUS FILTRATION; HORMONAL REGULATION; HUMAN; HYPERTENSION; HYPERURICEMIA; KIDNEY DISEASE; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; PURINE METABOLISM; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; VASCULAR DISEASE;

ANTIOXIDANTS; HUMANS; HYPERURICEMIA; MUSCLE, SMOOTH, VASCULAR; URIC ACID; VASCULAR DISEASES;

EID: 33645730376     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mnh.0000199010.33929.7f     Document Type: Review

References (41)

1. Lipkowitz MS, Leal-Pinto E, Rappoport JZ, et al. Functional reconstitution, membrane targeting, genomic structure and chromosomal localization of a human urate transporter. J Clin Invest 2001; 107:1103-1115.
2. Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature 2002; 417:447-452.
3. Ichida K, Hosoyamada M, Kimura H, et al. Urate transport via human PAH transporter hOAT1 and its gene structure. Kidney Int 2003; 63:143-155.
4. Hart TC, Gorry MC, Hart PS, et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet 2002; 39:882-892.
5. Choi HK, Atkinson K, Karlson EW, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 11;350:1093-1103. A 12-year prospective study of dietary factors associated with new cases of gout among 47,150 men which shows that meat and seafood consumption are associated with an increased risk of gout, whereas a consumption of dairy products is associated with a decreased risk.
6. Nakagawa T, Tuttle KR, Short RA, Johnson RJ. Fructose-induced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome Nature Clinical Practice Nephrology 2005 (in press). [Epub ahead of print].
7. Terkeltaub RA. Gout and mechanisms of crystal-induced inflammation. Curr Opin Rheumatol 1993; 5:510-516.
8. Johnson RJ, Kivlighn SD, Kim Y-G, et al. Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 1999; 33:225-234.
9. Ames BN, Cathcart R, Schwiers E, et al. Uric acid provides an antioxidant defense in humans against oxidant- and radical-causing aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 1981; 78:6853-6862.
10. Robinson KM, Morre JT, Beckman JS. Triuret: a novel product of peroxynitrite-mediated oxidation of urate. Arch Biochem Biophys 2004; 423:213-217.
11. Kuzkaya N, Weissmann N, Harrison DG, Dikalov S. Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol 2005; 70:343-354.
12. Hink HU, Santanam N, Dikalov S, et al. Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol 2002; 22:1402-1408.
13. Koprowski H, Spitsin SV, Hooper DC. Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann Neurol 2001; 49:139.
14. Orowan E. The origin of man. Nature 1955; 175:683-684.
15. Inouye E, Park KS, Asaka A. Blood uric acid level and IQ: a study in twin families. Acta Genet Med Gemellol (Roma) 1984; 33:237-242.
16. Johnson RJ, Kang D-HH., Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41:1183-1190.
17. Johnson RJ, Feig DI, Kang DH, Herrera-Acosta J. Resurrection of uric acid as a causal risk factor for essential hypertension. Hypertension 2005; 45:18-20.
18. Sündstrom J, Sullivan L, D'Agostino RB, et al. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005; 45:28-33. The authors showed that serum uric acid level was an independent predictor of hypertension incidence and longitudinal blood pressure progression at short-term follow-up in a community-based sample.
19. Alper AB, Chen W, Yau L, et al. Childhood uric acid predicts adult blood pressure: the Bogalusa Heart Study. Hypertension 2005; 45:34-38. This 12-year follow-up study suggests that early elevations in serum uric acid levels may play a key role in the development of human hypertension.
20. Nakanishi N, Okamato M, Yoshida H, et al. Serum uric acid and risk for development of hypertension and impaired fasting glucose or type II diabetes in Japanese male office workers. Eur J Epidemiol 2003; 18:523-530.
21. Masuo K, Kawaguchi H, Mikami H, et al. Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension 2003; 42:474-480.
22. Feig DI, Johnson RJ. Hyperuricemia in childhood essential hypertension. Hypertension 2003; 42:247-252.
23. Feig DI, Nakagawa T, Karumanchi SA, et al. Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney International 2004; 66:281-287.
24. Mazzali M, Hughes J, Kim YG, et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38:1101-1106.
25. Watanabe S, Kang DH, Feng L, et al. Uric acid, hominoid evolution and the pathogenesis salt-sensitivity. Hypertension 2002; 40:355-360.
26. Mazzali M, Kanellis J, Han L, et al. Hyperuricemia induces a primary arteriolopathy in rats by a blood pressure-independent mechanism. Am J Physiol Renal Physiol 2002; 282:F991-F997.
27. Nakagawa T, Mazzali M, Kang DH, et al. Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol 2003; 23:2-7.
28. Kang D, Nakagawa T, Feng L, et al. A role for uric acid in renal progression. J Am Soc Nephrol 2002; 13:2888-2897.
29. Kang DH, Han L, Ouyang X, et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 2005; 25:425-433. This paper established that urate enters VSMC by both voltage-sensitive and an organic anionic transport system.
30. Kang D-H, Park SK, Lee IK, Johnson RJ. Uric acid induced C-reactive protein (CRP) expression: implication on cell proliferation and nitric oxide production in human vascular cells. J Am Soc Nephrol (in press).
31. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991; 266:8604-8608.
32. Kanellis J, Watanabe S, Li JH, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003; 41:1287-1293.
33. Khosla UM, Zharikov S, Finch JL, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67:1739-1742. This study demonstrates that uric acid can induce endothelial dysfunction both in vitro and in vivo.
34. Sánchez-Lozada LG, Tapia E, Avila-Casado C, et al. Mild hyperuricemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 2002; 283:F1105-F1110.
35. Sánchez-Lozada LG, Tapia E, Santamaria J, et al. Mild hyperuricemia induces severe cortical vasoconstriction and perpetuates glomerular hypertension in normal rats and in experimental chronic renal failure. Kidney Int 2005; 67:237-247.
36. Johnson RJ, Rodriguez-Iturbe B, Kang DH, et al. A unifying pathway for essential hypertension. Am J Hypertens 2005; 18:431-440. This paper presents a novel theory that unites many of the previous hypotheses on the etiology of hypertension.
37. Herrera-Acosta J, Tapia E, Sánchez-Lozada LG, et al. Restoration of glomerular haemodynamics and renal injury independent of arterial hypertension in rats with subtotal renal ablation. J Hypertens Suppl 2002; 20:S29-S35.
38. Johnson RJ, Segal MS, Srinivas TR, et al. Essential hypertension, progressive renal disease and uric acid: a pathogenetic link? J Am Soc Nephrol 2005; 16:1909-1919. The authors hypothesize about the pathogenetic pathways mediating progressive renal damage in hypertensive subjects.
39. Myllymaki J, Honkanen T, Syrjanen J, et al. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Nephrol Dial Transplant 2005; 20:89-95.
40. Short RA, Johnson RJ, Tuttle KR. Uric acid, microalbuminuria, and cardiovascular events in high risk patients. Am J Nephrol 2005; 25:36-44.
41. Tseng CH. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int 2005; 68:796-801.